Back to Orbis Allan Gray Ltd

CRSP
6 quarters

Position history for Orbis Allan Gray Ltd's holdings in CRISPR THERAPEUTICS AG

Orbis Allan Gray Ltd holds 6.1M shares of CRSP (CRISPR THERAPEUTICS AG), worth $290.5M as of 2026-Q1. The position was increased (+2.6% shares). CRSP represents 1.2% of Orbis Allan Gray Ltd's portfolio.

Current Value

$290.5M

Current Shares

6.1M

Total Value Change

+$232.4M

Total Shares Change

+4.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
6.1M
+2.6%
$290.5M1.2%$58.06
50
2025-Q4
Increased
6M
+19.4%
$312M1.3%$53.19
58
2025-Q3
Increased
5M
+80.2%
$322.9M1.4%$63.77
75
2025-Q2
Increased
2.8M
+76.9%
$134.5M0.7%$47.49
65
2025-Q1
Increased
1.6M
+5.9%
$53.2M0.3%$36.99
37
2024-Q4
New
1.5M
-
$58.1M0.3%$38.65
49

Other major holders of CRSP: ARK Investment Management LLC, Capital International Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used